New cell therapy shows promise with acute respiratory distress syndrome patients
Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe COVID-19.
Feb 6, 2024
0
63